Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
TIS > SEC Filings for TIS > Form 8-K/A on 29-Jan-2014All Recent SEC Filings

Show all filings for ORCHIDS PAPER PRODUCTS CO /DE



Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously disclosed in a Current Report on Form 8-K dated November 15, 2013 (the "Original Filing"), effective November 8, 2013 Jeffrey S. Schoen was appointed President and Chief Executive Officer of Orchids Paper Products Company (the "Company"). In connection with Mr. Schoen's appointment, and at the recommendation of the Compensation Committee, the Board of Directors of the Company (the "Board") approved certain material terms of an employment agreement between the Company and Mr. Schoen (the "Employment Agreement"), with the final form to be finally negotiated between the parties. The Original Filing also set forth material terms of a conditional stock option granted to Mr. Schoen in connection with his appointment as President and Chief Executive Officer (the "Option"), the terms and conditions of which were to be set forth in a final form of a Nonqualified Stock Option Agreement (the "Option Agreement").

This Form 8-K/A is being filed to report that on January 23, 2014 the Company and Mr. Schoen entered to the final form of the Employment Agreement. The below descriptions of the terms and provisions of the Employment Agreement and the Option Agreement are summaries only and are fully qualified by reference to the full text of each agreement, copies of which are attached to this report as Exhibit 10.1 and Exhibit 10.2, respectively.

The Employment Agreement

Pursuant to the Employment Agreement, Mr. Schoen is an at-will employee and either party may terminate the Employment Agreement at any time. The Employment Agreement provides that Mr. Schoen is entitled to an initial base salary of $400,000 per annum, subject to annual review and increase in the discretion of the Compensation Committee. Further, Mr. Schoen is potentially entitled to the following bonus payments: (i) an annual performance bonus in an amount up to 100% of then current base salary (target bonus of 60% of base salary) based on achievement of such targets as shall be established in accordance with the Company's annual bonus program and prorated as necessary for any partial year, including 2013; and (ii) a one-time bonus payment of $50,000 (each a "Stock Threshold Bonus") if and when the share price of the Common Stock closes at or above each of the following prices for three consecutive business days at any point during the five years following November 8, 2013: $34.7875, $42.35, $51.425, or $60.50. Only one Stock Threshold Bonus payment shall be paid for reaching any one threshold, and the aggregate Stock Threshold Bonus payable is limited to $200,000. All payments under the Employment Agreement are intended to be exempt from Section 409A as short-term deferrals.

Under the Employment Agreement Mr. Schoen is entitled to certain other benefits, including the cost of reasonable temporary living in the Tulsa, Oklahoma area for up to 12 months, as well as the reimbursement of certain relocation costs incurred by Mr. Schoen.

If Mr. Schoen's employment is terminated without "Cause" or with "Good Reason" within 12 months following a change in control event, then pursuant to the terms of the Employment Agreement, and subject to execution of a release agreement, Mr Schoen would be entitled to: (i) all earned and accrued but unpaid base salary, and (ii) severance consisting of an amount equal to two years of base salary plus an amount equal to twice the average of the annualized previous two bonus payments (but excluding the Stock Threshold Bonus), payable in one lump sum within 90 days following termination of employment. In the event of Mr. Schoen's death or disability the Company would be obligated to pay Mr. Schoen's estate all earned and accrued but unpaid base salary, and a pro-rated bonus.

For two years following the termination of Mr. Schoen's employment he has an obligation to inform the Company of any new work location and responsibilities he assumes and will be subject to restrictive covenants relating to the solicitation of employees of the Company. Also, if he receives severance, during that time Mr. Schoen will be subject to restrictive covenants relating to the solicitation of customers and suppliers of the Company.

The Option Agreement

As disclosed in the Original Filing, on November 8, subject to shareholder approval, the Board granted Mr. Schoen the Option which provides Mr. Schoen the option to purchase up to 400,000 shares of the common stock of the Company (the "Common Stock") at a purchase price of $30.25 per share, which is the arithmetic mean between the high and low prices of such stock as reported on such date and was deemed the fair market value of the Company's Common Stock on the date of grant. The Option will become exercisable, if at all, if and when the share price of the Common Stock closes at a certain percentage of the purchase price of the Option for three consecutive business days, in accordance with the below vesting schedule, subject to Mr. Schoen being employed by the Company on such date and subject further to certain change in control provisions also described below. However, in no event shall the Option become vested prior to the date that shareholder approval of the Option is obtained:

Share price closes at or above the following     Number of shares that become vested
percentage of the purchase price for the Option
                      115%                                     100,000
                      140%                                     100,000
                      170%                                     100,000
                      200%                                     100,000

Any unvested portion of the Option shall expire five years from the date of grant ("Option Period"), and the Option shall terminate after 10 years after date of grant. The Option will immediately become 100% vested in the total number of shares to which this Option relates immediately prior to a Change in Control, provided such Change in Control occurs within the Option Period.

  Add TIS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for TIS - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.